图书馆订阅: Guest
神经生物学评论综述™

每年出版 3 

ISSN 打印: 0892-0915

ISSN 在线: 2375-0014

SJR: 0.121

Serotonin 5-HT2A Receptors: Molecular Biology and Mechanisms of Regulation

卷 12, 册 4, 1998, pp. 319-338
DOI: 10.1615/CritRevNeurobiol.v12.i4.30
Get accessGet access

摘要

Serotonin 5-HT2A receptors are essential for a large number of physiological functions in the central nervous system and periphery. This review article summarizes our current knowledge of the molecular biology and mechanisms of regulation of 5-HT2A receptors. The mode of drug binding using data derived from molecular modeling and site-directed mutagenesis is described. The cellular and subcellular localization of 5-HT2A receptors is described, and the concentration of 5-HT2A receptors on apical dendrites of pyramidal neurons is emphasized. Various modes of regulation of 5-HT2A receptors are also summarized, including transcriptional, post-translational and mRNA editing processes. Finally, an integrated model of 5-HT2A receptor regulation that involves various protein kinases (protein kinase C, G-protein receptor kinases), arrestins, clathrin-coated vesicles, endosomes and lysosomes. The relevance of these pathways for antidepressant and antipsychotic drug actions is emphasized.

对本文的引用
  1. Kling Anders, Mjörndal Tom, Rantapää-Dahlqvist Solbritt, Glucocorticoid treatment increases density of serotonin 5-HT2A receptors in humans, Psychoneuroendocrinology, 38, 7, 2013. Crossref

  2. Snir O, Hesselberg E, Amoudruz P, Klareskog L, Zarea-Ganji I, Catrina A I, Padyukov L, Malmström V, Seddighzadeh M, Genetic variation in the serotonin receptor gene affects immune responses in rheumatoid arthritis, Genes & Immunity, 14, 2, 2013. Crossref

  3. Grados Marco, Wilcox Holly C, Genetics of obsessive–compulsive disorder: a research update, Expert Review of Neurotherapeutics, 7, 8, 2007. Crossref

  4. López-Giménez Juan F., Vilaró M. Teresa, Palacios José M., Mengod Guadalupe, Multiple conformations of 5-HT2A and 5-HT2C receptors in rat brain: an autoradiographic study with [125I](±)DOI, Experimental Brain Research, 230, 4, 2013. Crossref

  5. Erritzoe D., Frokjaer V.G., Haahr M.T., Kalbitzer J., Svarer C., Holst K.K., Hansen D.L., Jernigan T.L., Lehel S., Knudsen G.M., Cerebral serotonin transporter binding is inversely related to body mass index, NeuroImage, 52, 1, 2010. Crossref

  6. Cao Jian, Liu Xiangtao, Han Shizhong, Zhang Clarence K., Liu Zongzhi, Li Dawei, Association of the HTR2A gene with alcohol and heroin abuse, Human Genetics, 133, 3, 2014. Crossref

  7. Kupers Ron, Frokjaer Vibe G., Naert Arne, Christensen Rune, Budtz-Joergensen Esben, Kehlet Henrik, Knudsen Gitte M., A PET [18F]altanserin study of 5-HT2A receptor binding in the human brain and responses to painful heat stimulation, NeuroImage, 44, 3, 2009. Crossref

  8. Tylš Filip, Páleníček Tomáš, Horáček Jiří, Psilocybin – Summary of knowledge and new perspectives, European Neuropsychopharmacology, 24, 3, 2014. Crossref

  9. Prabhakaran Jaya, Parsey Ramin V., Majo Vattoly J., Van Heertum Ronald L., John Mann J., Dileep Kumar J. S., Synthesis andin vivo evaluation of [O-methyl-11C] 2-(4-methoxyphenyl)-N-(4-methylbenzyl)-N-(1-methyl- piperidin-4-yl)acetamide as an imaging probe for 5-HT2A receptors, Journal of Labelled Compounds and Radiopharmaceuticals, 49, 12, 2006. Crossref

  10. Gray John A., Roth Bryan L., Serotonin Systems, in Handbook of Contemporary Neuropharmacology, 2007. Crossref

  11. Rambousek Lukas, Palenicek Tomas, Vales Karel, Stuchlik Ales, The Effect of Psilocin on Memory Acquisition, Retrieval, and Consolidation in the Rat, Frontiers in Behavioral Neuroscience, 8, 2014. Crossref

  12. Melkersson Kristina I., Gunes Arzu, Dahl Marja-Liisa, Impact of serotonin receptor 2A gene haplotypes on C-peptide levels in clozapine- and olanzapine-treated patients, Human Psychopharmacology: Clinical and Experimental, 25, 4, 2010. Crossref

  13. George S.E., Schaeffer M.T., Cully D., Beer M.S., McAllister G., A High-Throughput Glow-Type Aequorin Assay for Measuring Receptor-Mediated Changes in Intracellular Calcium Levels, Analytical Biochemistry, 286, 2, 2000. Crossref

  14. Li Qian, Wichems Christine H., Ma Li, Van de Kar Louis D., Garcia Francisca, Murphy Dennis L., Brain region-specific alterations of 5-HT2Aand 5-HT2Creceptors in serotonin transporter knockout mice, Journal of Neurochemistry, 84, 6, 2003. Crossref

  15. Davydova S. M., Cheido M. A., Gevorgyan M. M., Idova G. V., Effects of 5-HT2A Receptor Stimulation and Blocking on Immune Response, Bulletin of Experimental Biology and Medicine, 150, 2, 2010. Crossref

  16. Robinson Michael B., Regulated trafficking of neurotransmitter transporters: common notes but different melodies, Journal of Neurochemistry, 80, 1, 2001. Crossref

  17. Touri F, Welker E, Riederer B.M, Differential distribution of MAP1A isoforms in the adult mouse barrel cortex and comparison with the serotonin 5-HT2A receptor, Journal of Chemical Neuroanatomy, 27, 2, 2004. Crossref

  18. Frank Guido K, Kaye Walter H, Meltzer Carolyn C, Price Julie C, Greer Phil, McConaha Claire, Skovira Kelli, Reduced 5-HT2A receptor binding after recovery from anorexia nervosa, Biological Psychiatry, 52, 9, 2002. Crossref

  19. Zea-Ponce Yolanda, Kegeles Lawrence S, Guo Ningning, Raskin Leonid, Bakthavachalam Venkatesalu, Laruelle Marc, Pharmacokinetics and brain distribution in non human primate of R(-)[123I]DOI, A 5HT2A/2C serotonin agonist, Nuclear Medicine and Biology, 29, 5, 2002. Crossref

  20. Dave Kuldip D., Quinn Jennifer L., Harvey John A., Aloyo Vincent J., Role of central 5-HT2 receptors in mediating head bobs and body shakes in the rabbit, Pharmacology Biochemistry and Behavior, 77, 3, 2004. Crossref

  21. Nichols Charles D., Sanders-Bush Elaine, Serotonin, in Encyclopedia of the Neurological Sciences, 2003. Crossref

  22. Wappler F., Fiege M., Schulte am Esch J., Pathophysiological role of the serotonin system in malignant hyperthermia, British Journal of Anaesthesia, 87, 5, 2001. Crossref

  23. Frokjaer Vibe G., Mortensen Erik L., Nielsen Finn Å., Haugbol Steven, Pinborg Lars H., Adams Karen H., Svarer Claus, Hasselbalch Steen G., Holm Soeren, Paulson Olaf B., Knudsen Gitte M., Frontolimbic Serotonin 2A Receptor Binding in Healthy Subjects Is Associated with Personality Risk Factors for Affective Disorder, Biological Psychiatry, 63, 6, 2008. Crossref

  24. Moser Andreas, Thümen Ansgar, Qadri Fatimunnisa, Modulation of striatal serotonin and opioid receptor mRNA expression following systemic N-methyl-norsalsolinol administration, Journal of the Neurological Sciences, 216, 1, 2003. Crossref

  25. Kumar J.S. Dileep, Prabhakaran Jaya, Erlandsson Kjell, Majo Vattoly J., Simpson Norman R., Pratap Mali, Van Heertum Ronald L., Mann J. John, Parsey Ramin V., Synthesis and in vivo evaluation of [O-methyl-11C](2R,4R)-4-hydroxy-2-[2-[2-[2-(3-methoxy)phenyl]ethyl]phenoxy]ethyl-1-methylpyrrolidine as a 5-HT2A receptor PET ligand, Nuclear Medicine and Biology, 33, 4, 2006. Crossref

  26. Dave Kuldip D, Harvey John A, Aloyo Vincent J, A novel behavioral model that discriminates between 5-HT2A and 5-HT2C receptor activation, Pharmacology Biochemistry and Behavior, 72, 1-2, 2002. Crossref

  27. Carrasco G.A., Van de Kar L.D., Sullivan N.R., Landry M., Garcia F., Muma N.A., Battaglia G., Cocaine-mediated supersensitivity of 5-HT2A receptors in hypothalamic paraventricular nucleus is a withdrawal-induced phenomenon, Neuroscience, 143, 1, 2006. Crossref

  28. Gray John A, Roth Bryan L, Paradoxical trafficking and regulation of 5-HT2A receptors by agonists and antagonists, Brain Research Bulletin, 56, 5, 2001. Crossref

  29. Lidow Michael S, Song Zan-Min, Castner Stacy A, Allen Patrick B, Greengard Paul, Goldman-Rakic Patricia S, Antipsychotic treatment induces alterations in dendrite- and spine-associated proteins in dopamine-rich areas of the primate cerebral cortex, Biological Psychiatry, 49, 1, 2001. Crossref

  30. Schwartzer Jared J., Ricci Lesley A., Melloni Richard H., Adolescent anabolic-androgenic steroid exposure alters lateral anterior hypothalamic serotonin-2A receptors in aggressive male hamsters, Behavioural Brain Research, 199, 2, 2009. Crossref

  31. Zhang Gongliang, Stackman Robert W., The role of serotonin 5-HT2A receptors in memory and cognition, Frontiers in Pharmacology, 6, 2015. Crossref

  32. Noordam Raymond, Aarts Nikkie, Leening Maarten J. G., Tiemeier Henning, Franco Oscar H., Hofman Albert, Stricker Bruno H., Visser Loes E., Use of antidepressants and the risk of myocardial infarction in middle-aged and older adults: a matched case-control study, European Journal of Clinical Pharmacology, 72, 2, 2016. Crossref

  33. Versijpt J., Van Laere K.J., Dumont F., Decoo Danny, Vandecapelle Marleen, Santens Patrick, Goethals Ingeborg, Audenaert K., Slegers G., Dierckx Rudi A., Korf Jakob, Imaging of the 5-HT2A system: age-, gender-, and Alzheimer’s disease-related findings, Neurobiology of Aging, 24, 4, 2003. Crossref

  34. Cornea-Hébert V, Watkins K.C, Roth B.L, Kroeze W.K, Gaudreau P, Leclerc N, Descarries L, Similar ultrastructural distribution of the 5-HT2A serotonin receptor and microtubule-associated protein MAP1A in cortical dendrites of adult rat, Neuroscience, 113, 1, 2002. Crossref

  35. Nichols David E, Hallucinogens, Pharmacology & Therapeutics, 101, 2, 2004. Crossref

  36. Fehr Christoph, Schleicher Alexandra, Szegedi Armin, Anghelescu Ion, Klawe Christoph, Hiemke Christoph, Dahmen Norbert, Serotonergic polymorphisms in patients suffering from alcoholism, anxiety disorders and narcolepsy, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 25, 5, 2001. Crossref

  37. Shelton R.C., Sanders-Bush E., Manier D.H., Lewis D.A., Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A, Neuroscience, 158, 4, 2009. Crossref

  38. McDonald A.J., Mascagni F., Neuronal localization of 5-HT type 2A receptor immunoreactivity in the rat basolateral amygdala, Neuroscience, 146, 1, 2007. Crossref

  39. Scheler G., Schumann J., Presynaptic modulation as fast synaptic switching: state-dependent modulation of task performance, Proceedings of the International Joint Conference on Neural Networks, 2003., 1, 2003. Crossref

  40. Allen John A., Yadav Prem N., Roth Bryan L., Insights into the regulation of 5-HT2A serotonin receptors by scaffolding proteins and kinases, Neuropharmacology, 55, 6, 2008. Crossref

  41. de Veen Bas T.H., Schellekens Arnt F.A., Verheij Michel M.M., Homberg Judith R., Psilocybin for treating substance use disorders?, Expert Review of Neurotherapeutics, 17, 2, 2017. Crossref

  42. Tyls Filip, Palenicek Tomas, Horacek Jiri, Neurobiology of the Effects of Psilocybin in Relation to Its Potential Therapeutic Targets, in Neuropathology of Drug Addictions and Substance Misuse, 2016. Crossref

  43. SANDYK REUVEN, SEROTONERGIC MECHANISMS IN AMYOTROPHIC LATERAL SCLEROSIS, International Journal of Neuroscience, 116, 7, 2006. Crossref

  44. Bohn Laura M., Schmid Cullen L., Serotonin receptor signaling and regulation via β-arrestins, Critical Reviews in Biochemistry and Molecular Biology, 45, 6, 2010. Crossref

  45. Singh RK, Jia C., Garcia F., Carrasco GA, Battaglia G., Muma NA, Activation of the JAK-STAT pathway by olanzapine is necessary for desensitization of serotonin2A receptor-stimulated phospholipase C signaling in rat frontal cortex but not serotonin2A receptor-stimulated hormone release, Journal of Psychopharmacology, 24, 7, 2010. Crossref

  46. Karaki Samah, Becamel Carine, Murat Samy, Mannoury la Cour Clotilde, Millan Mark J., Prézeau Laurent, Bockaert Joël, Marin Philippe, Vandermoere Franck, Quantitative Phosphoproteomics Unravels Biased Phosphorylation of Serotonin 2A Receptor at Ser280 by Hallucinogenic versus Nonhallucinogenic Agonists, Molecular & Cellular Proteomics, 13, 5, 2014. Crossref

  47. Zhang Yong, Liang Yupu, Randesi Matthew, Yuferov Vadim, Zhao Connie, Kreek Mary Jeanne, Chronic Oxycodone Self-administration Altered Reward-related Genes in the Ventral and Dorsal Striatum of C57BL/6J Mice: An RNA-seq Analysis, Neuroscience, 393, 2018. Crossref

  48. De Deurwaerdère Philippe, Drutel Guillaume, Di Giovanni Giuseppe, Pharmacological Analysis in Favour of a Physiological Role for the Constitutive Activity of 5-HT2A Receptors in Learning, in 5-HT2A Receptors in the Central Nervous System, 2018. Crossref

  49. Flanagan Thomas W., Nichols Charles D., Psychedelics as anti-inflammatory agents, International Review of Psychiatry, 30, 4, 2018. Crossref

  50. Laux G., Fritze J., König W., Dietmaier O., König F., Nicht-selektive Monoamin- Rückaufnahme-Inhibitoren (NSMRI), in Neuro-Psychopharmaka Ein Therapie-Handbuch, 2002. Crossref

  51. Xia Zongqi, Sheffler Douglas J., Roth Bryan L., 5-HT Receptor-Associated Proteins (FRAPs), in The Serotonin Receptors, 2006. Crossref

  52. Davies Marilyn A., Chang Chiao-ying, Roth Bryan L., Polymorphic and Posttranscriptional Modifications of 5-HT Receptor Structure, in The Serotonin Receptors, 2006. Crossref

  53. Dave Kuldip D., Harvey John A., Aloyo Vincent J., The Time-Course for Up- and Down-Regulation of the Cortical 5-Hydroxytryptamine (5-HT)2A Receptor Density Predicts 5-HT2A Receptor-Mediated Behavior in the Rabbit, Journal of Pharmacology and Experimental Therapeutics, 323, 1, 2007. Crossref

  54. Shapiro David A., Kristiansen Kurt, Kroeze Wesley K., Roth Bryan L., Differential Modes of Agonist Binding to 5-Hydroxytryptamine2A Serotonin Receptors Revealed by Mutation and Molecular Modeling of Conserved Residues in Transmembrane Region 5, Molecular Pharmacology, 58, 5, 2000. Crossref

  55. Shi Ju, Damjanoska Katerina J., Singh Rakesh K., Carrasco Gonzalo A., Garcia Francisca, Grippo Angela J., Landry Michelle, Sullivan Nicole R., Battaglia George, Muma Nancy A., Agonist Induced-Phosphorylation of Gα11Protein Reduces Coupling to 5-HT2AReceptors, Journal of Pharmacology and Experimental Therapeutics, 323, 1, 2007. Crossref

  56. Fagni Laurent, Diversity of Metabotropic Glutamate Receptor–Interacting Proteins and Pathophysiological Functions, in Synaptic Plasticity, 970, 2012. Crossref

  57. Hazelwood Lisa A., Sanders-Bush Elaine, His452Tyr Polymorphism in the Human 5-HT2A Receptor Destabilizes the Signaling Conformation, Molecular Pharmacology, 66, 5, 2004. Crossref

  58. Carrasco Gonzalo A., Zhang Yahong, Damjanoska Katerina J., D'Souza Deborah N., Garcia Francisca, Battaglia George, Muma Nancy A., Van de Kar Louis D., A Region-Specific Increase in Gαq And Gα11 Proteins in Brains of Rats during Cocaine Withdrawal, Journal of Pharmacology and Experimental Therapeutics, 307, 3, 2003. Crossref

  59. Carrasco Gonzalo A., Damjanoska Katerina J., D'Souza Deborah N., Zhang Yahong, Garcia Francisca, Battaglia George, Muma Nancy A., Van de Kar Louis D., Short-Term Cocaine Treatment Causes Neuroadaptive Changes in Gαq and Gα11 Proteins in Rats Undergoing Withdrawal, Journal of Pharmacology and Experimental Therapeutics, 311, 1, 2004. Crossref

  60. Gray John A., Sheffler Douglas J., Bhatnagar Anushree, Woods Jason A., Hufeisen Sandra J., Benovic Jeffrey L., Roth Bryan L., Cell-Type Specific Effects of Endocytosis Inhibitors on 5-Hydroxytryptamine2AReceptor Desensitization and Resensitization Reveal an Arrestin-, GRK2-, and GRK5-Independent Mode of Regulation in Human Embryonic Kidney 293 Cells, Molecular Pharmacology, 60, 5, 2001. Crossref

  61. De Deurwaerdère Philippe, Bharatiya Rahul, Chagraoui Abdeslam, Di Giovanni Giuseppe, Constitutive activity of 5-HT receptors: Factual analysis, Neuropharmacology, 168, 2020. Crossref

  62. Eischens Peter, Atherton William Leigh, Psychedelic therapy as a complementary treatment approach for alcohol use disorders, Journal of Psychedelic Studies, 2, 1, 2018. Crossref

  63. Runyon Scott P., Mosier Philip D., Roth Bryan L., Glennon Richard A., Westkaemper Richard B., Potential Modes of Interaction of 9-Aminomethyl-9,10-dihydroanthracene (AMDA) Derivatives with the 5-HT2A Receptor: A Ligand Structure-Affinity Relationship, Receptor Mutagenesis and Receptor Modeling Investigation, Journal of Medicinal Chemistry, 51, 21, 2008. Crossref

  64. Perry Stephen J., Junger Sachiko, Kohout Trudy A., Hoare Sam R.J., Struthers R. Scott, Grigoriadis Dimitri E., Maki Richard A., Distinct Conformations of the Corticotropin Releasing Factor Type 1 Receptor Adopted following Agonist and Antagonist Binding Are Differentially Regulated, Journal of Biological Chemistry, 280, 12, 2005. Crossref

  65. Castensson Anja, Emilsson Lina, Preece Paul, Jazin and Elena, High-resolution Quantification of Specific mRNA Levels in Human Brain Autopsies and Biopsies, Genome Research, 10, 8, 2000. Crossref

  66. Aguiar Rafael Pazinatto de, Newman-Tancredi Adrian, Prickaerts Jos, Oliveira Rúbia Maria Weffort de, The 5-HT1A receptor as a serotonergic target for neuroprotection in cerebral ischemia, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 109, 2021. Crossref

  67. Flanagan Thomas W., Sebastian Melaine N., Battaglia Diana M., Foster Timothy P., Cormier Stephania A., Nichols Charles D., 5-HT2 receptor activation alleviates airway inflammation and structural remodeling in a chronic mouse asthma model, Life Sciences, 236, 2019. Crossref

  68. Bhatnagar Anushree, Willins David L., Gray John A., Woods Jason, Benovic Jeffrey L., Roth Bryan L., The Dynamin-dependent, Arrestin-independent Internalization of 5-Hydroxytryptamine 2A (5-HT2A) Serotonin Receptors Reveals Differential Sorting of Arrestins and 5-HT2A Receptors during Endocytosis, Journal of Biological Chemistry, 276, 11, 2001. Crossref

  69. Basile V S, Ozdemir V, Masellis M, Meltzer H Y, Lieberman J A, Potkin S G, Macciardi F M, Petronis A, Kennedy J L, Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia, Molecular Psychiatry, 6, 2, 2001. Crossref

  70. Shirakawa Osamu, Kitamura Noboru, Lin Xian-Hao, Hashimoto Takeshi, Maeda Kiyoshi, Abnormal neurochemical asymmetry in the temporal lobe of schizophrenia, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 25, 4, 2001. Crossref

  71. Mayberry Colleen L., Wilczek Michael P., Fong Tristan M., Nichols Sarah L., Maginnis Melissa S., Banks Lawrence, GRK2 Mediates β-Arrestin Interactions with 5-HT 2 Receptors for JC Polyomavirus Endocytosis , Journal of Virology, 95, 7, 2021. Crossref

  72. Hámor Peter U., Šírová Jana, Páleníček Tomáš, Zaniewska Magdalena, Bubeníková-Valešová Věra, Schwendt Marek, Chronic methamphetamine self-administration dysregulates 5-HT2A and mGlu2 receptor expression in the rat prefrontal and perirhinal cortex: Comparison to chronic phencyclidine and MK-801, Pharmacology Biochemistry and Behavior, 175, 2018. Crossref

  73. Davies M A, Setola V, Strachan R T, Sheffler D J, Salay E, Hufeisen S J, Roth B L, Pharmacologic analysis of non-synonymous coding h5-HT2A SNPs reveals alterations in atypical antipsychotic and agonist efficacies, The Pharmacogenomics Journal, 6, 1, 2006. Crossref

  74. Kulikova E.A., Khotskin N.V., Illarionova N.B., Sorokin I.E., Bazhenova E.Y., Kondaurova E.M., Volcho K.P., Khomenko T.M., Salakhutdinov N.F., Ponimaskin E., Naumenko V.S., Kulikov A.V., Inhibitor of Striatal-Enriched Protein Tyrosine Phosphatase, 8-(Trifluoromethyl)-1,2,3,4,5-Benzopentathiepin-6-Amine hydrochloride (TC-2153), Produces Antidepressant-Like Effect and Decreases Functional Activity and Protein Level of 5-HT2A Receptor in the Brain, Neuroscience, 394, 2018. Crossref

  75. Peritore Carina S, The promise of psychedelic research, Future Drug Discovery, 4, 1, 2022. Crossref

  76. Barre Alexander, Berthoux Coralie, De Bundel Dimitri, Valjent Emmanuel, Bockaert Joël, Marin Philippe, Bécamel Carine, Presynaptic serotonin 2A receptors modulate thalamocortical plasticity and associative learning, Proceedings of the National Academy of Sciences, 113, 10, 2016. Crossref

  77. Mayberry Colleen L., Soucy Ashley N., Lajoie Conner R., DuShane Jeanne K., Maginnis Melissa S., Dermody Terence S., JC Polyomavirus Entry by Clathrin-Mediated Endocytosis Is Driven by β-Arrestin, Journal of Virology, 93, 8, 2019. Crossref

  78. Sousa Teresa Reynolds, Rema João, Machado Sergio, Novais Filipa, Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets, Current Topics in Medicinal Chemistry, 22, 15, 2022. Crossref

Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集 订购及政策 Begell House 联系我们 Language English 中文 Русский Português German French Spain